Pharmabiz :: Precision BioSciences sues Cellectis for patent infringement

Precision BioSciences, Inc., the world leader in rational genome engineering, announced that it has filed a lawsuit against Cellectis SA and its affiliates Cellectis bioresearch and Cellectis bioresearch Inc. in the US District Court for the Eastern District of North Carolina. The lawsuit seeks a ruling that Cellectis’ manufacture, use and sale of certain engineered meganucleases infringe US Patent No. 8,021,867, a recently-issued patent...